Yahoo Finance 
European Cannabis Market Sizing Data & Adult-Use Cannabis Supplement Report: €354 Million Worth of Unlicensed Medical Cannabis Forecast to be Sold in Europe in 2022
Dublin, April 19, 2022 (GLOBE NEWSWIRE) -- The "European Cannabis Report with Market Sizing Data & Adult-Use Cannabis Supplement" report has been added to ResearchAndMarkets.com's offering.
2021 was another huge year for the liberalisation and mainstreaming of cannabis in Europe.
Legislation, regulations and market developments continued to evolve for the better. Many countries continued to improve their medical cannabis access schemes, and the publisher estimates that €354 million worth of unlicensed medical cannabis will be sold in Europe in 2022, and this could reach to €2.3 billion in 2026.
CBD products are continuing their path towards recognition as fully-legal consumer packaged goods (CPGs). As of 2022, several novel foods applications for CBD have been validated by the European Commission.
But, the story which is drawing most international attention is the upcoming liberalisation of adult-use cannabis in Europe, with the ruling coalition of Germany promising full legalisation and commercialisation of adult-use cannabis in this legislative term. Legal sales are set to start in Switzerland by the end of 2022 followed shortly by those in the Netherlands.
Key Topics Covered:
Market Sizing
Unlicensed Medical Cannabis Sales in Europe
Projected Sales of Adult Use Cannabis in Europe
CBD Sales in Europe
Country Focus
Expert Interviews
Benedikt Sons, Cansativa Group
Jakob Sons, Cansativa Group
Timo Bongartz, Fluence EMEA
Dr Anne Schlag, Project Twenty21
Bek Muslimov & Nikolay Tretiyakov, Leafy Tunnel
Denise Fatischek, Tilray
CBD
Fragmented European Markets
CBD Legislation in Europe
CBD as a Cosmetic
CBD as a Medicine
Ingestible CBD
CBD Flowers
Trends
Medical Cannabis Pilot Trials
Supply Chain
Product Shortages in Europe
Countries Allowing Cultivation in Europe
Patients and Products
Expert Interviews
Country Focus
Germany
Italy
The Netherlands
Poland
United Kingdom
Switzerland
Czechoslovakia
Companies Mentioned
4C Labs
Brains Bio
Canna-X
Cannabis Europa
Cannavigia
Cansativa Group
Cantourage
CBDepot.eu
Fluence
Linnea
MGC Pharma
Perfect Plants
SOMAI Pharmaceuticals
Storz & Bickel
For more information about this report visit https://www.researchandmarkets.com/r/vd8iwj
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
